Mark L. Day
- Behavioral Neuroscience top 1%
-
- Neuroscience and Neuropharmacology Research 17
- Developmental Neuroscience top 2%
- Immunology and Allergy top 2%
- Biological Psychiatry top 5%
-
- Cancer-related gene regulation 12
- Wnt/β-catenin signaling in development and cancer 10
-
- Bladder and Urothelial Cancer Treatments 12
-
- Prostate Cancer Treatment and Research 12
-
- HER2/EGFR in Cancer Research 10
- Cancer-related Molecular Pathways 9
- Peptidase Inhibition and Analysis 9
- Co-authors
- Kathleen C. DayMichael T. McCabeRichard MorrisMark A. RubinAbdo J. NajyRainer KueferMin‐Wei ChenRalph Buttyan
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark L. Day
114 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 142
- Behavioral Neuroscience 407
- Cellular and Molecular Neuroscience 1.3k
- Developmental Neuroscience 229
- Immunology and Allergy 308
- Biological Psychiatry 119
Countries citing papers authored by Mark L. Day
This map shows the geographic impact of Mark L. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Day more than expected).
Fields of papers citing papers by Mark L. Day
This network shows the impact of papers produced by Mark L. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Day. The network helps show where Mark L. Day may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark L. Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 12 | |
| 4 | 2019 | 24 | |
| 5 | 2018 | 17 | |
| 6 | 2016 | 145 | |
| 7 | 2015 | 8 | |
| 8 | 2013 | 52 | |
| 9 | 2010 | 22 | |
| 10 | 2010 | 49 | |
| 11 | 2010 | 93 | |
| 12 | 2010 | 27 | |
| 13 | 2008 | 73 | |
| 14 | 2008 | 154 | |
| 15 | 2006 | 113 | |
| 16 | 2004 | 40 | |
| 17 | 2003 | 2 | |
| 18 | 2001 | 39 | |
| 19 | 2001 | 21 | |
| 20 | 1997 | 101 |
About Mark L. Day
Mark L. Day is a scholar working on Behavioral Neuroscience, Microbiology, Cellular and Molecular Neuroscience, Oncology and Immunology and Allergy, having authored 117 papers that have together received 6.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (17 papers), Cancer-related gene regulation (12 papers), Bladder and Urothelial Cancer Treatments (12 papers), Prostate Cancer Treatment and Research (12 papers), Wnt/β-catenin signaling in development and cancer (10 papers), HER2/EGFR in Cancer Research (10 papers), Cancer-related Molecular Pathways (9 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Behavioral Neuroscience (407 citations), Cellular and Molecular Neuroscience (1.3k citations), Developmental Neuroscience (229 citations), Immunology and Allergy (308 citations) and Biological Psychiatry (119 citations). Mark L. Day has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kathleen C. Day, Michael T. McCabe, Richard Morris, Mark A. Rubin, Abdo J. Najy, Rainer Kuefer, Min‐Wei Chen, Ralph Buttyan, Anthony J. Raffo and Harris Perlman. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Oncogene, Journal of Pharmacology and Experimental Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.